PRADAXA 110 MG GRANULADO RECUBIERTO

Boehringer Ingelheim International Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2a2f6fa64bb427ec
Drug Cima Aemps Name: PRADAXA 110 MG GRANULADO RECUBIERTO
Register Number: 108442029
Holder Company Name: Boehringer Ingelheim International Gmbh
Marketing Company Name: Boehringer Ingelheim Espana S.A.
Holder Company Detail Path: /organization/boehringer-ingelheim-international-gmbh
Authorization Date: 2022-03-08
Dosage Form: GRANULADO RECUBIERTO
Dose: 110 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Boehringer Ingelheim International Gmbh
Company Detail Path: /organization/boehringer-ingelheim-international-gmbh

DABIGATRAN ETEXILATO MESILATO

126,83 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 8, 2022

Approval ID

2a2f6fa64bb427ec

Type

Standard